2024 annual financial data
Celldex Therapeutics 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was -2,247.55%.
Operating income was -195,078,000 USD and net income was -157,863,000 USD.
Operating cash flow was -157,778,000 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,020,000 USD
- Operating income
- -195,078,000 USD
- Net income
- -157,863,000 USD
- Operating cash flow
- -157,778,000 USD